Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AFSCME Health and Welfare Fund v. Pfizer, Inc. et al
Case Number:
3:14-cv-00482
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
July 18, 2014
Pfizer Celebrex Suits Should Be Coordinated, Judge Hears
Two employee benefit administrators on Thursday asked a Virginia federal court to transfer to a different division their putative class actions against Pfizer over an alleged generic delay agreement involving Celebrex in order to coordinate similar claims filed by the American Sales Company Inc.
-
July 07, 2014
Pfizer Faces 3 Class Actions Over Generic Delay Scheme
Pfizer Inc. has been hit with three class actions alleging it improperly obtained a patent from the U.S. Patent and Trademark Office for its arthritis drug Celebrex and used it to induce generic manufacturers into settlements to delay their versions of the drug from entering the market.